<qa>  What will be examined in relation to established risk scores calculated from clinical parameters?The clinical utility of biomarkers will be examined in relation to established risk scores calculated from clinical parameters, to determine whether this biomarker of bone-heart-kidney axis can extend the forecast evaluation of patients. 